Publications - William Chapman

PubMed Page

  • Seetharam AB, Borg BB, Subramanian V, Chapman WC, Crippin JS, Mohanakumar T. Temporal Association Between Increased Virus-Specific Th17 Response and Spontaneous Recovery From Recurrent Hepatitis C in a Liver Transplant Recipient. Transplantation. 2011 Nov 11. [Epub ahead of print]
  • Conzen KD, Lowell JA, Chapman WC, Darcy M, Duncan JR, Nadler M, Turmelle YP, Shepherd RW, Anderson CD. Management of excluded bile ducts in paediatric orthotopic liver transplant recipients of technical variant allografts. HPB (Oxford). 2011 Dec;13(12):893-8.
  • Subramanian V, Seetharam AB, Vachharajani N, Tiriveedhi V, Angaswamy N, Ramachandran S, Crippin JS, Shenoy S, Chapman WC, Mohanakumar T, Anderson CD. Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation. Transplantation. 2011 Dec 15;92(11):1259-68.
  • DuBray BJ Jr, Levy RV, Balachandran P, Conzen KD, Upadhya GA, Anderson CD, Chapman WC. Novel three-dimensional imaging technique improves the accuracy of hepatic volumetric assessment. HPB (Oxford). 2011 Sep;13(9):670-4.
  • DuBray BJ Jr, Chapman WC, Anderson CD. Hepatocellular carcinoma: a review of the surgical approaches to management. Mo Med. 2011 May-Jun;108(3):195-8.
  • Lennerz JK, Chapman WC, Brunt EM. Keratin 19 epithelial patterns in cirrhotic stroma parallel hepatocarcinogenesis. Am J Pathol. 2011 Aug;179(2):1015-29.
  • Earl TM, Chapman WC. Conventional Surgical Treatment of Hepatocellular Carcinoma. Clin Liver Dis. 2011 May;15(2):353-70, vii-x.
  • Lin Y, Chapman WC. Towards more effective liver allocation criteria for hepatocellular carcinoma: tumor response to locoregional therapy. Ann Surg Oncol. 2011 Sep;18(9):2416-8.
  • Basha HI, Subramanian V, Seetharam A, Nath DS, Ramachandran S, Anderson CD, Shenoy S, Chapman WC, Crippin JS, Mohanakumar T. Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. Am J Transplant. 2011 Apr;11(4):775-85.
  • Borg BB, Seetharam A, Subramanian V, Basha HI, Lisker-Melman M, Korenblat K, Anderson CD, Shenoy S, Chapman WC, Crippin JS, Mohanakumar T. Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis. Liver Transpl. 2011 Jul;17(7):814-23.
  • Earl TM, Chapman WC. Tumor size remains key for prediction of hepatocellular carcinoma recurrence after liver transplantation. Ann Surg Oncol. 2011 May;18(5):1217-8.
  • Anderson CD, Upadhya G, Conzen KD, Jia J, Brunt EM, Tiriveedhi V, Xie Y, Ramachandran S, Mohanakumar T, Davidson NO, Chapman WC. Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts. Liver Transpl. 2011 Feb;17(2):189-200.
  • Earl TM, Wellen JR, Anderson CD, Nadler M, Doyle MM, Shenoy SS, Chapman WC, Turmelle Y, Weymann A, Lowell JA. Small bowel obstruction after pediatric liver transplantation: the unusual is the usual. J Am Coll Surg. 2011 Jan;212(1):62-7.
  • Doyle MB, Vachharajani N, Wellen JR, Anderson CD, Lowell JA, Shenoy S, Brunt EM, Chapman WC. Short- and long-term outcomes after steatotic liver transplantation. Arch Surg. 2010 Jul;145(7):653-60.
  • Bowman LJ, Anderson CD, Chapman WC. Topical recombinant human thrombin in surgical hemostasis. Semin Thromb Hemost. 2010 Jul;36(5):477-84.
  • Jarnagin W, Chapman WC, Curley S, D'Angelica M, Rosen C, Dixon E, Nagorney D; American Hepato-Pancreato-Biliary Association; Society of Surgical Oncology; Society for Surgery of the Alimentary Tract. Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010 Jun;12(5):302-10.
  • Doyle MB, Chapman WC. Radiofrequency ablation for resectable colorectal hepatic metastases: is it time for a randomized controlled trial? Ann Surg. 2010 May;251(5):804-6.
  • Ballard JL, Weaver FA, Singla NK, Chapman WC, Alexander WA. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin. J Am Coll Surg. 2010 Feb;210(2):199-204.
  • Chapman WC. Fluorescent in situ hybridization testing in primary sclerosing cholangitis: useful testing or a random chance result? Hepatology. 2010 Jan;51(1):16-9.
  • Anderson CD, Turmelle YP, Darcy M, Shepherd RW, Weymann A, Nadler M, Guelker S, Chapman WC, Lowell JA. Biliary strictures in pediatric liver transplant recipients - early diagnosis and treatment results in excellent graft outcomes. Pediatr Transplant. 2010 May;14(3):358-63.
  • Chapman WC. No silver bullet in liver transection: what has 35 years of new technology added to liver surgery? Ann Surg. 2009 Aug;250(2):204-5.
  • Wellen JR, Anderson CD, Doyle M, Shenoy S, Nadler M, Turmelle Y, Shepherd R, Chapman WC, Lowell JA. The role of liver transplantation for hepatic adenomatosis in the pediatric population: case report and review of the literature. Pediatr Transplant. 2010 May;14(3):E16-9.
  • Bender LC, Klingensmith ME, Freeman BD, Chapman WC, Dunagan WC, Gottlieb JE, Hall BL. Anonymous group peer review in surgery morbidity and mortality conference. Am J Surg. 2009 Aug;198(2):270-6.
  • Anderson CD, Vachharajani N, Doyle M, Lowell JA, Wellen JR, Shenoy S, Lisker-Melman M, Korenblat K, Crippin J, Chapman WC. Advanced donor age alone does not affect patient or graft survival after liver transplantation. J Am Coll Surg. 2008 Dec;207(6):847-52.
  • Anderson CD, Bowman LJ, Chapman WC. Topical use of recombinant human thrombin for operative hemostasis. Expert Opin Biol Ther. 2009 Jan;9(1):133-7.
  • Snow D, Cohen D, Chapman WC, Grubb RL 3rd. Positron emission tomography enhancing tumor thrombus in patient with renal cell carcinoma. Urology. 2009 Feb;73(2):270-1.
  • Chapman WC, Majella Doyle MB, Stuart JE, Vachharajani N, Crippin JS, Anderson CD, Lowell JA, Shenoy S, Darcy MD, Brown DB. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg. 2008 Oct;248(4):617-25.
  • Clements LW, Chapman WC, Dawant BM, Galloway RL Jr, Miga MI. Robust surface registration using salient anatomical features for image-guided liver surgery: algorithm and validation. Med Phys. 2008 Jun;35(6):2528-40.
  • Doyle MB, Anderson CD, Vachharajani N, Lowell JA, Shenoy S, Lisker-Melman M, Korenblat K, Crippin JS, Chapman WC. Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival. Arch Surg. 2008 Jul;143(7):679-85; discussion 685.
  • Tessier DJ, Iglesias R, Chapman WC, Kercher K, Matthews BD, Gorden DL, Brunt LM. Previously unreported high-grade complications of adrenalectomy. Surg Endosc. 2009 Jan;23(1):97-102
  • Schaberg FJ Jr, Doyle MB, Chapman WC, Vollmer CM Jr, Zalieckas JM, Birkett DH, Miner TJ, Mazzaglia PJ. Incidental findings at surgery. Part 1. Curr Probl Surg. 2008 May;45(5):325-74
  • Schaberg FJ Jr, Doyle MB, Chapman WC, Vollmer CM Jr, Zalieckas JM, Birkett DH, Miner TJ, Mazzaglia PJ. Incidental findings at surgery. Part 1. In brief. Curr Probl Surg. 2008 May;45(5):320-2
  • Elsayes KM, Leyendecker JR, Menias CO, Oliveira EP, Narra VR, Chapman WC, Hassanien MH, Elsharkawy MS, Brown JJ. MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility. HPB (Oxford). 2007;9(3):208-15.
  • Chapman WC. Liver paper summary: IHPBA meeting 2004, Washington, DC. HPB (Oxford). 2005;7(3):164-5.
  • Brown DB, Chapman WC, Cook RD, Kerr JR, Gould JE, Pilgram TK, Darcy MD. Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center. AJR Am J Roentgenol. 2008 Mar;190(3):608-15.
  • Bharat A, Narayanan K, Golocheikine A, Steward N, Crippin J, Lisker-Melman M, Shenoy S, Lowell J, Chapman WC, Mohanakumar T. Elevated soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis. Transplantation. 2007 Dec 27;84(12):1704-7.
  • Bharat A, Saini D, Benshoff N, Goodman J, Desai NM, Chapman WC, Mohanakumar T. Role of intra-islet endothelial cells in islet allo-immunity. Transplantation. 2007 Nov 27;84(10):1316-23.
  • Ho CK, Chapman WC, Brown DB. Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up. J Vasc Interv Radiol. 2007 Nov;18(11):1451-3.
  • Chapman WC. Primary sclerosing cholangitis: role of liver transplantation. J Gastrointest Surg. 2008 Mar;12(3):426-8.
  • Chapman WC, Singla N, Genyk Y, McNeil JW, Renkens KL Jr, Reynolds TC, Murphy A, Weaver FA. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg. 2007 Aug;205(2):256-65.
  • Glasgow SC, Ramachandran S, Blackwell TS, Mohanakumar T, Chapman WC. Interleukin-1beta is the primary initiator of pulmonary inflammation following liver injury in mice. Am J Physiol Lung Cell Mol Physiol. 2007 Aug;293(2):L491-6.
  • Vauthey JN, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, Lerut J, Chapman WC, Hemming AW, Neuhaus P. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg. 2007 May;204(5):1016-27; discussion 1027-8.
  • Cash DM, Miga MI, Glasgow SC, Dawant BM, Clements LW, Cao Z, Galloway RL, Chapman WC.Concepts and preliminary data toward the realization of image-guided liver surgery. J Gastrointest Surg. 2007 Jul;11(7):844-59.